Australia - English - Department of Health (Therapeutic Goods Administration)

hetero australia pty ltd - lamivudine, quantity: 300 mg; abacavir sulfate, quantity: 702.762 mg (equivalent: abacavir, qty 600 mg) - tablet - excipient ingredients: sodium starch glycollate; microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; titanium dioxide; hypromellose; sunset yellow fcf; polysorbate 80; macrogol 400 - abalamid hetero 600/300 tablets are a combinaton of two nucleoside analogues (abacavir and lamivudine). abalamid hetero 600/300 is indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infection in adults and adolescents from 12 years of age.

Australia - English - Department of Health (Therapeutic Goods Administration)

hetero australia pty ltd - lamivudine, quantity: 300 mg; abacavir sulfate, quantity: 702.762 mg (equivalent: abacavir, qty 600 mg) - tablet - excipient ingredients: sodium starch glycollate; microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; titanium dioxide; hypromellose; sunset yellow fcf; polysorbate 80; macrogol 400 - abalamid hetero 600/300 tablets are a combinaton of two nucleoside analogues (abacavir and lamivudine). abalamid hetero 600/300 is indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infection in adults and adolescents from 12 years of age.

Australia - English - Department of Health (Therapeutic Goods Administration)

hetero australia pty ltd - lamivudine, quantity: 300 mg; abacavir sulfate, quantity: 702.762 mg (equivalent: abacavir, qty 600 mg) - tablet - excipient ingredients: sodium starch glycollate; magnesium stearate; microcrystalline cellulose; colloidal anhydrous silica; titanium dioxide; hypromellose; sunset yellow fcf; polysorbate 80; macrogol 400 - abalamid hetero 600/300 tablets are a combinaton of two nucleoside analogues (abacavir and lamivudine). abalamid hetero 600/300 is indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infection in adults and adolescents from 12 years of age.

Australia - English - Department of Health (Therapeutic Goods Administration)

hetero australia pty ltd - lamivudine, quantity: 300 mg; abacavir sulfate, quantity: 702.762 mg (equivalent: abacavir, qty 600 mg) - tablet - excipient ingredients: microcrystalline cellulose; sodium starch glycollate; magnesium stearate; colloidal anhydrous silica; titanium dioxide; hypromellose; sunset yellow fcf; polysorbate 80; macrogol 400 - bacamid 600/300 tablets are a combinaton of two nucleoside analogues (abacavir and lamivudine). bacamid 600/300 is indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infection in adults and adolescents from 12 years of age.

Australia - English - Department of Health (Therapeutic Goods Administration)

hetero australia pty ltd - lamivudine, quantity: 300 mg; abacavir sulfate, quantity: 702.762 mg (equivalent: abacavir, qty 600 mg) - tablet - excipient ingredients: microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; sodium starch glycollate; titanium dioxide; hypromellose; sunset yellow fcf; polysorbate 80; macrogol 400 - bacamid 600/300 tablets are a combinaton of two nucleoside analogues (abacavir and lamivudine). bacamid 600/300 is indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infection in adults and adolescents from 12 years of age.

Australia - English - Department of Health (Therapeutic Goods Administration)

hetero australia pty ltd - lamivudine, quantity: 300 mg; abacavir sulfate, quantity: 702.762 mg (equivalent: abacavir, qty 600 mg) - tablet - excipient ingredients: microcrystalline cellulose; sodium starch glycollate; magnesium stearate; colloidal anhydrous silica; titanium dioxide; hypromellose; sunset yellow fcf; polysorbate 80; macrogol 400 - bacamid 600/300 tablets are a combinaton of two nucleoside analogues (abacavir and lamivudine). bacamid 600/300 is indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infection in adults and adolescents from 12 years of age.

Australia - English - Department of Health (Therapeutic Goods Administration)

hetero australia pty ltd - lamivudine, quantity: 300 mg; abacavir sulfate, quantity: 702.762 mg (equivalent: abacavir, qty 600 mg) - tablet - excipient ingredients: microcrystalline cellulose; magnesium stearate; sodium starch glycollate; colloidal anhydrous silica; titanium dioxide; hypromellose; sunset yellow fcf; polysorbate 80; macrogol 400 - cavadexa 600/300 tablets are a combinaton of two nucleoside analogues (abacavir and lamivudine). cavadexa 600/300 is indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infection in adults and adolescents from 12 years of age.

Australia - English - Department of Health (Therapeutic Goods Administration)

hetero australia pty ltd - lamivudine, quantity: 300 mg; abacavir sulfate, quantity: 702.762 mg (equivalent: abacavir, qty 600 mg) - tablet - excipient ingredients: sodium starch glycollate; colloidal anhydrous silica; microcrystalline cellulose; magnesium stearate; titanium dioxide; hypromellose; sunset yellow fcf; polysorbate 80; macrogol 400 - cavadexa 600/300 tablets are a combinaton of two nucleoside analogues (abacavir and lamivudine). cavadexa 600/300 is indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infection in adults and adolescents from 12 years of age.

Australia - English - Department of Health (Therapeutic Goods Administration)

hetero australia pty ltd - lamivudine, quantity: 300 mg; abacavir sulfate, quantity: 702.762 mg (equivalent: abacavir, qty 600 mg) - tablet - excipient ingredients: sodium starch glycollate; colloidal anhydrous silica; microcrystalline cellulose; magnesium stearate; titanium dioxide; hypromellose; sunset yellow fcf; polysorbate 80; macrogol 400 - cavadexa 600/300 tablets are a combinaton of two nucleoside analogues (abacavir and lamivudine). cavadexa 600/300 is indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infection in adults and adolescents from 12 years of age.

Australia - English - Department of Health (Therapeutic Goods Administration)

hetero australia pty ltd - lamivudine, quantity: 300 mg; abacavir sulfate, quantity: 702.762 mg (equivalent: abacavir, qty 600 mg) - tablet - excipient ingredients: microcrystalline cellulose; colloidal anhydrous silica; sodium starch glycollate; magnesium stearate; titanium dioxide; hypromellose; sunset yellow fcf; polysorbate 80; macrogol 400 - lamavir 600/300 tablets are a combinaton of two nucleoside analogues (abacavir and lamivudine). lamavir 600/300 is indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infection in adults and adolescents from 12 years of age.